NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Thursday that its fourth-quarter revenues increased 15 percent year over year as the firm missed consensus Wall Street estimates on the top line but easily beat it on the bottom line.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.